Tenax Therapeutics names Thomas Staab CFO

Tenax Therapeutics has appointed Thomas Staab as its new Chief Financial Officer. Staab brings extensive financial leadership experience to the company. His appointment is expected to bolster Tenax Therapeutics' financial strategy and operational management as it continues its development in the biotechnology sector. The company anticipates leveraging his expertise to drive future growth and financial stability.